Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study
伊沃西尼布或伊那西尼布联合强化化疗治疗新诊断急性髓系白血病患者:一项 1 期研究
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2020007233
Stein, Eytan M; DiNardo, Courtney D; Fathi, Amir T; Mims, Alice S; Pratz, Keith W; Savona, Michael R; Stein, Anthony S; Stone, Richard M; Winer, Eric S; Seet, Christopher S; Döhner, Hartmut; Pollyea, Daniel A; McCloskey, James K; Odenike, Olatoyosi; Löwenberg, Bob; Ossenkoppele, Gert J; Patel, Prapti A; Roshal, Mikhail; Frattini, Mark G; Lersch, Frederik; Franovic, Aleksandra; Nabhan, Salah; Fan, Bin; Choe, Sung; Wang, Hongfang; Wu, Bin; Hua, Lei; Almon, Caroline; Cooper, Michael; Kantarjian, Hagop M; Tallman, Martin S